BRCA1 and BRCA2 germline mutations useful for predicting genetic predisposition of breast cancer or ovarian cancer

• 1. 用于检测遗传乳腺癌BRCA1和BRCA2基因突变的引物组合物及试剂盒 [P] . 中国专利： CN109295232A . 2019-02-01
• 2. 遗传性乳腺癌与卵巢癌BRCA1/2基因热点突变位点检测试剂盒 [P] . 中国专利： CN107523609A . 2017-12-29
• 3. BRCA1 AND BRCA2 GERMLINE MUTATIONS USEFUL FOR PREDICTING GENETIC PREDISPOSITION OF BREAST CANCER OR OVARIAN CANCER [P] . 韩国专利： KR20130057760A . 2013-06-03

  机译： 预测乳腺癌或卵巢癌的遗传易感性的BRCA1和BRCA2生殖突变

• 4. BRCA2 GERMLINE MUTATIONS USEFUL FOR PREDICTING GENETIC PREDISPOSITION OF BREAST CANCER OR OVARIAN CANCER [P] . 韩国专利： KR20130100075A . 2013-09-09

  机译： BRCA2基因突变可用于预测乳腺癌或卵巢癌的遗传易感性

• 5. BRCA2 germline mutations useful for predicting genetic predisposition of breast cancer or ovarian cancer [P] . 韩国专利： KR101323101B1 . 2013-10-30

  机译： BRCA2种系突变可用于预测乳腺癌或卵巢癌的遗传易感性

• 1. Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients [J] . Xingsheng Hu, Pengbo Deng, Junyi Ye, 癌症生物学与医学（英文版 ） . 2020,第002期
• 2. Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients [J] . Xingsheng Hu, Dongyong Yang, Yalun Li, 癌症生物学与医学：英文版 . 2020,第002期
• 3. Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients [J] . Xingsheng Hu, Pengbo Deng, Junyi Ye, 癌症生物学与医学（英文版 ） . 2019,第003期
• 4. BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. [J] . Peixoto A, Salgueiro N, Santos C, Familial cancer . 2006,第4期
• 5. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants. [J] . Delgado L, Fernandez G, Grotiuz G, Breast cancer research and treatment. . 2011,第1期
• 6. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants [J] . L. Delgado, G. Fernández, G. Grotiuz, Breast Cancer Research and Treatment . 2011,第1期
• 7. An Integrated Microfluidic Platform for Detecting BRCA1/BRCA2 Gene Mutation and Risk Assessment of Ovarian Cancer [C] . Yu-Hung Cheng, Chih-Hung Wang, Keng-Fu Hsu, International Conference on Solid-State Sensors, Actuators and Microsystems . 2021
• 8. Breast cancer risk after chemoprevention in BRCA1 versus BRCA2 mutation carriers. [D] . Shaver, Jamie. 2011
• 9. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers [O] . Ewa Przybytkowski, Thomas Davis, Abdelrahman Hosny, 2020
• 10. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers [O] . Ewa Przybytkowski, Thomas Davis, Abdelrahman Hosny, 2020

• 1. Should multi-gene panel testing replace limited BRCA1/2 testing? A review of genetic testing for hereditary breast and ovarian cancers [J] . Nimmi S Kapoor ,Kimberly C Banks . 世界外科手术杂志 . 2016,第1期
• 2. International Szent-Gyorgyi Prize for Progress in Cancer Research:basic and translational research recognition Mary-Claire King received the 2016 Prize for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer [J] . Hali Hartmann ,Jie Zhao ,Sujuan Ba . 癌症 . 2017,第11期
• 3. PrECOG 0105试验:iniparib、卡铂、吉西他滨联合用于新辅助治疗早期三阴性及BRCA1/2突变相关乳腺癌的疗效及预测因素研究 [C] . 李弋 ,王耀辉 ,陆劲松 . 第四届上海浦东乳腺癌高峰论坛 . 2016
• 4. 遗传性乳腺癌卵巢癌BRCA1突变状况的评价及未患病亲属遗传易感性的检测 [A] . 李宁 . 2003